METHODES DE TRAITEMENT DU CANCER ET UTILISATION DE BIOMARQUEURS EN TANT QUE FACTEURS PREDICTIFS DE LA SENSIBILITE CLINIQUE A DES TRAITEMENTS

• 收藏
• 分享

专利权人:

CELGENE CORPORATION

发明人:

FILVAROFF, ELLEN,LOPEZ-GIRONA, ANTONIA,LU, GANG

申请号：

CA3010801

公开号：

CA3010801A1

申请日:

2017.01.06

申请国别(地区):

CA

年份:

2017

代理人:

摘要：

A method of identifying a subject having cancer who is likely to be responsive to a treatment compound, comprising administering the treatment compound to the subject having the cancer； obtaining a sample from the subject； determining the level of a biomarker in the sample from the subject； and diagnosing the subject as being likely to be responsive to the treatment compound if the level of the biomarker in the sample of the subject changes as compared to a reference level of the biomarker； wherein the treatment compound is a compound of Formula I:

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/